[Increase in resistance of mice toward acute hypoxia by means of apressin in combination with other compounds].
D000208:Acute Disease; D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000818:Animals; D002746:Chlorpromazine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005971:Glutamates / Q000627:therapeutic use; D006830:Hydralazine / Q000627:therapeutic use*; D000860:Hypoxia / Q000517:prevention & control*; D008297:Male; D008715:Methionine / Q000627:therapeutic use; D051379:Mice; D009388:Neostigmine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D013268:Stimulation, Chemical
D005971:Glutamates; D010276:Parasympatholytics; D010862:Pilocarpine; D006830:Hydralazine; D009388:Neostigmine; D012110:Reserpine; D004155:Diphenhydramine; D000255:Adenosine Triphosphate; D012964:Sodium; D008715:Methionine; D002746:Chlorpromazine
Povyshenie ustoĭchivesti mysheĭ k ostroĭ gipoksii s pomoshch'iu apressina v kombinatsii s drugimi veshcehstvami.